Showing results (701-710 of 11,013) with videos related to
Sort By:
Pageof 1,102
Journal of the National Cancer Institute|July 1, 1986
Cancer incidence in a cohort of patients with seizure disordersS B Shirts, J F Annegers, W A Hauser, et al.Journal of the National Cancer Institute|July 1, 1986
Dietary fat, adipose tissue composition, and the development of carcinoma of the colonE M Berry, J Zimmerman, M Peser, et al.Journal of the National Cancer Institute|April 28, 2022
An Evaluation of Sex- and Gender-Based Analyses in Oncology Clinical TrialsMathew Hall, Vaishali A Krishnanandan, Matthew C Cheung, et al.Journal of the National Cancer Institute|March 1, 1987
Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animalsM C Bibby, J A Double, S A Ali, et al.Journal of the National Cancer Institute|February 1, 1987
Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibodyD P Dubey, D E Staunton, A C Parekh, et al.Journal of the National Cancer Institute|February 1, 1987
Pathologic anatomy and patterns of occurrence of hepatic neoplasms, putative preneoplastic lesions, and other idiopathic hepatic conditions in English sole (Parophrys vetulus) from Puget Sound, WashingtonM S Myers, L D Rhodes, B B McCainJournal of the National Cancer Institute|April 19, 2022
Charting a Path Towards Asian American Cancer Health Equity: A Way ForwardMoon S Chen, Richard J Lee, Ravi A Madan, et al.Journal of the National Cancer Institute|June 22, 2019
Overdiagnosis and Lives Saved by Reflex Testing Men With Intermediate Prostate-Specific Antigen LevelsRoman Gulati, Todd M Morgan, Teresa A'mar, et al.Journal of the National Cancer Institute|October 9, 2019
Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective StudyOana A Zeleznik, Clary B Clish, Peter Kraft, et al.Journal of the National Cancer Institute|April 20, 1988
Effects of dimethyl sulfoxide treatment on H-2 expression and susceptibility to NK- or cytotoxic T-lymphocyte-mediated lysis of the YAC-1 lymphoma and its beta 2-microglobulin-deficient variantT Yamasaki, G Klein, H G Ljunggren, et al.Pageof 1,102